SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Array Biopharma, Inc
An SI Board Since March 2005
Posts SubjectMarks Bans Symbol
321 29 0 ARRY
Emcee:  keokalani'nui Type:  Moderated
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
21William Blair & Company Initiates Coverage of Array BioPharma Inc. With OutpLJM-2/7/2008
20Boulder, Colo., (December 19, 2007) - Array BioPharma Inc. (NASDAQ: ARRY) today keokalani'nui-12/19/2007
19Anyone here still following ARRY?caly-12/17/2007
18Array BioPharma and Celgene Corporation Announce Strategic Global R&D Collabnigel bates-9/24/2007
17Array BioPharma Reports New Clinical Data on Its Anti-Inflammatory Drugs MEK InLJM-6/20/2007
16Array BioPharma Inc. Announces Pricing of Proposed Public Offering of Common StoLJM-5/2/2007
15Array BioPharma Advances p38 Inhibitor, ARRY-797, into Phase 1 Cancer Patient TrLJM-4/10/2007
14FDA Approves Advanced Breast Cancer Drug Tuesday March 13, 5:00 pm ET By Andrew dr.praveen-3/13/2007
13Array BioPharma's p38 Inhibitor for Inflammatory Disease to Advance into Humdr.praveen-10/31/2006
12Array BioPharma Reports MEK Inhibitor, ARRY-438162, Meets Initial Clinical Objecnigel bates-10/19/2006
11Nice to be a part of the ITMN action:-) But Array gets only 3% :-( Not a big upsdr.praveen-10/16/2006
10wow! biz.yahoo.com To look at after hours price, maybe some are expecting goodSteve Lokness-10/16/2006
9GlaxoSmithKline Seeks Cancer Drug OK Monday September 18, 4:44 pm ET GlaxoSmithKdr.praveen-9/19/2006
8In the last nine months they appear to be delivering on the pipeline promises.keokalani'nui-8/14/2006
7<i>Some info on Tykerb and ARRY-334543 from ACS magazine Message 22716588 tnsaf-8/14/2006
6Array BioPharma Achieves Milestone for Selection of Third Compound for MEK Anti-nigel bates-4/10/2006
5Array's lead program is a dual ERB inhibitor, just like lapatinib. I'keokalani'nui-11/30/2005
4Sorry for the dumb question .... What is the connection between (Lapatinib or John McCarthy-11/30/2005
3GSK. Lapatinib = Tykerb <i> * Tykerb - a targeted oral therapy with thekeokalani'nui-11/30/2005
2Appears to me ARRY has been very careful to not talk about the AZN economics. Skeokalani'nui-3/24/2005
1Price: $7.37 MC: $282m c/s: 38.3m at 1/31 () Cash: $98m at 12/30 (last finankeokalani'nui-3/24/2005
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):